Cargando…

25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype

CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, K. S., Assar, S., Harnpanich, D., Bouillon, R., Lambrechts, D., Prentice, A., Schoenmakers, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207933/
https://www.ncbi.nlm.nih.gov/pubmed/24885631
http://dx.doi.org/10.1210/jc.2014-1714
Descripción
Sumario:CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and 25(OH)D status. PARTICIPANTS: Healthy men (aged 24 and 39 y), resident in The Gambia (n = 18) or the United Kingdom (n = 18) participated in the study. INTERVENTIONS: The intervention included an oral tracer dose of deuterated-25(OH)D(2) and deuterated-25(OH)D(3) (both 40 nmol). Blood samples were collected over 33 days. MAIN OUTCOME MEASURES: 25(OH)D(2) and 25(OH)D(3) plasma half-lives, concentrations of 25(OH)D, and vitamin D binding protein (DBP) and DBP genotypes were measured. RESULTS: 25(OH)D(2) half-life [mean (SD)] [13.9 (2.6) d] was shorter than 25(OH)D(3) half-life [15.1 (3.1) d; P = .001] for countries combined, and in Gambians [12.8 (2.3) d vs 14.7 (3.5) d; P < .001], but not in the United Kingdom [15.1 (2.4) d vs 15.6 (2.5) d; P = .3]. 25(OH)D concentration was 69 (13) and 29 (11) nmol/L (P < .0001), and the DBP concentration was 259 (33) and 269 (23) mg/L (P = .4) in The Gambia and United Kingdom, respectively. Half-lives were positively associated with plasma DBP concentration for countries combined [25(OH)D(2) half-life: regression coefficient (SE) 0.03 (0.01) d per 1 mg/L DBP, P = .03; 25(OH)D(3) half-life: 0.04 (0.02) d, P = .02] and in Gambians [25(OH)D(2) half-life: 0.04 (0.01) d; P = .02; 25(OH)D(3) half-life: 0.06 (0.02) d, P = .01] but not in UK participants. The DBP concentration × country interactions were not significant. DBP Gc1f/1f homozygotes had shorter 25(OH)D(2) half-lives compared with other combined genotypes (P = .007) after correction for country. CONCLUSIONS: 25(OH)D(2) half-life was shorter than 25(OH)D(3) half-life, and half-lives were affected by DBP concentration and genotype. The stable isotope 25(OH)D half-life measurements provide a novel tool to investigate vitamin D metabolism and vitamin D expenditure and aid in the assessment of vitamin D requirements.